Tirzepatide is a novel dual agonist peptide that targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This 10mg vial of high-purity, research-grade Tirzepatide is designed exclusively for scientific investigation into metabolic regulation, glucose homeostasis, and energy balance. This procuct is for research purposes only.